文献速递胰腺与胆道疾病消化内镜

胰腺内镜治疗对慢性胰腺炎患者生活质量的影响

The impact of pancreatic endotherapy on quality of life in chronic pancreatitis.
PubMed 文献 · Gastrointest Endosc · 2024-12-09

这项单中心前瞻性研究纳入120例慢性胰腺炎患者,在胰腺内镜治疗前及治疗后1、3、6、12个月评估生活质量、疼痛及阿片类药物使用。生活质量评分在1、3、6、12个月均显著改善,6个月时改善最大(平均增加15.5分);疼痛在1和6个月显著改善但12个月无显著改善;阿片类药物使用在所有随访点均减少。

要点

  • 胰腺内镜治疗后1、3、6、12个月生活质量评分均显著改善,6个月时平均增加15.5分。
  • 疼痛水平在1和6个月显著改善,但12个月时无显著改善。
  • 阿片类药物使用在所有随访点均减少。

核心结论

  • 胰腺内镜治疗与治疗后1年内生活质量改善相关,但疼痛改善仅见至6个月,反映该患者群体疼痛管理的复杂性。
  • 需要进一步研究以预测内镜治疗的应答者。

研究设计与样本

  • 单中心前瞻性研究,纳入120例慢性胰腺炎患者(平均年龄52.3岁,女性58.3%)。
  • 使用经验证的慢性胰腺炎特异性生活质量工具,在内镜治疗开始前及治疗后1、3、6、12个月评估生活质量、疼痛水平和阿片类药物使用。
  • 采用重复测量混合效应模型比较内镜治疗前后各随访点的生活质量变化。

主要发现

  • 内镜治疗方式主要包括治疗性胰管支架置入(49.2%)、超声内镜引导下腹腔神经丛阻滞(32.5%)和胰管结石碎石(16.7%)。
  • 生活质量评分在内镜治疗完成后1、3、6、12个月均显著改善,6个月时改善最大(平均增加15.5分)。
  • 疼痛水平在1和6个月显著改善,但12个月时无显著改善。
  • 阿片类药物使用在所有随访点均减少。

局限性

  • 需要进一步研究以预测内镜治疗的应答者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Pancreatic endotherapy (PET) offers a treatment option for adverse events of chronic pancreatitis (CP) such as pancreatic duct (PD) strictures, stones, and pseudocysts. Previous studies have primarily focused on how PET affects pain, so the primary aim of this study was to evaluate the effect of PET on quality of life. METHODS: This single-center prospective study assessed quality of life before the initiation of endotherapy using a validated CP-specific quality of life instrument. Quality of life, pain levels, and opiate use were also measured at 1, 3, 6, and 12 months' follow-up. PET modalities included therapeutic PD stent placement, PD stone lithotripsy, endoscopic ultrasound (EUS)-guided pseudocyst drainage, and celiac plexus block (EUS-CPB). A repeated-measures mixed effects model was used to compare pre- and post-PET changes in quality of life at each follow-up point. RESULTS: A total of 120 subjects with CP (mean age 52.3 years, 58.3% female) were included in this study. PET modalities consisted primarily of therapeutic PD stenting (49.2%), EUS-CPB (32.5%), and PD stone lithotripsy (16.7%). Significant improvements in quality of life scores were seen at 1, 3, 6, and 12 months after PET completion, with the greatest improvement seen at 6 months (mean increase of 15.5 points). Significant improvements in pain levels were seen at 1 and 6 months, but not at 12 months. Decrease in opiate use was seen at all follow-up points. CONCLUSIONS: PET is associated with improvement in quality of life up to 1 year after treatment, but pain improvement was seen only to 6 months, reflecting the complexity of pain management in this difficult patient population. Further studies are needed to predict responders to endotherapy.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Han S, Rueb N, Nikahd M, et al. The impact of pancreatic endotherapy on quality of life in chronic pancreatitis. Gastrointest Endosc. 2024. PMID: 39662636. doi:10.1016/j.gie.2024.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。